Taylor & Francis
Biomatter
(ISSN 2159-2535)
Aims and scope
This title has ceased 2016.
Biomatter is published as a fully open access, online-only journal! This allows authors free access to and distribution of published articles
Scope of Biomatter: Recent developments in medicine have resulted in a considerable and unprecedented increase in life span. The invention of artificial implants made from biomaterials, in the 1960s, created a whole new scientific field and resulted in revolutionary technologies that strongly contributed to this increase in life expectancy. Since then, many exciting advancements shaped the modern biomaterials science, which itself originated several new fields, with biology playing a major role and where the separation between engineering and health sciences can hardly be distinguishable. Current and future research efforts in this field are believed to result in new therapeutic approaches to prevent and treat debilitating and life-threatening diseases.
Biomatter covers all types of synthetic and natural biomaterials (metals, ceramics, polymers and composites) used for biomedical applications.
About Biomatter: Biomatter appears as a forum to discuss and disclose the relevant advancements in the exciting and fast growing field of science and application of biomaterials. It is widely anticipated that current and future developments will soon result in products with potential to dramatically change the way in which we live, probably even with yet unimaginable future implications in healthcare.
Biomatter is an international and transdisciplinary journal for publication of peer-reviewed original research exploring the clinical and laboratory investigations in the field of science and application of biomaterials, including their physico-chemical and biological properties, as well as clinical performance, and especially those emphasizing the correlation between biomaterials structure and biological performance. The journal intends to cover all applications of biomaterials, including implantable medical devices, drug delivery systems, nanomedicine, tissue engineering and regenerative medicine.
Biomatter is intended to help researchers, academics, clinicians, industry professionals and policy makers, working in related fields of science, engineering and health sciences, to disseminate information associated to biomaterials and its related fields.
Contents and Topics: Biomatter publishes original articles, review articles, short communications and letters to the Editor. Biomatter covers, but is not limited to, the following topics in the context of biomaterials science:
Advanced materials
Animal Models
Antimicrobial strategies
Artificial cells, tissues and organs
Biocompatibility studies
Biodegradable materials
Bioethics
Biological response
Biomaterials synthesis and characterization
Biomimetic strategies
Bioreactors
Biosensors and screening devices
Blood substitutes
Cell engineering
Cell, tissue and organ transplantation
Clinical Trials
Drug delivery systems
Experimental methodologies
Fluid dynamics, modeling and simulation
Gene therapy
In vitro and in vivo approaches
Interactions between materials and cells and proteins
Medical devices
Nanomedicine and nanotechnology
Regenerative medicine
Regulatory and ethical issues
Repair, replacement and Regeneration
Self-Assembly
Smart multifunctional intelligent systems
Stem cell biology
Structure-property-function relationship
Surfaces, interfaces and functionalization
Tissue engineering
Biomatter is an Open Access journal, all accepted manuscripts will be freely available online immediately upon publication. All authors must sign one of the Open Access License Agreements.
Open Access License
Type of Paper
Fee
CC-BY-NC license
Report
Short Report
Review
Commentary
$1000
$750
$750
$500
CC-BY license
Report
Short Report
Review
Commentary
$2000
$1500
$1500
$1000
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.